Thrivent Financial for Lutherans
AMPH icon

Thrivent Financial for Lutherans’s Amphastar Pharmaceuticals AMPH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Sell
23,618
-695
-3% -$17K ﹤0.01% 2253
2025
Q4 		$651K Sell
24,313
-1,515
-6% -$39K ﹤0.01% 2150
2025
Q3 		$688K Sell
25,828
-1,208
-4% -$31.2K ﹤0.01% 1964
2025
Q2 		$621K Sell
27,036
-511
-2% -$12.7K ﹤0.01% 2041
2025
Q1 		$799K Sell
27,547
-1,441
-5% -$46K ﹤0.01% 1854
2024
Q4 		$1.08M Sell
28,988
-827
-3% -$37.8K ﹤0.01% 1850
2024
Q3 		$1.45M Sell
29,815
-1,850
-6% -$81.2K ﹤0.01% 1672
2024
Q2 		$1.27M Sell
31,665
-752
-2% -$31.2K ﹤0.01% 1708
2024
Q1 		$1.42M Sell
32,417
-880
-3% -$45.4K ﹤0.01% 1669
2023
Q4 		$2.06M Sell
33,297
-30,633
-48% -$1.61M ﹤0.01% 1350
2023
Q3 		$2.94M Sell
63,930
-24,201
-27% -$1.32M 0.01% 1044
2023
Q2 		$5.07M Buy
88,131
+50,772
+136% +$2.25M 0.01% 845
2023
Q1 		$1.4M Sell
37,359
-1,310
-3% -$42.9K ﹤0.01% 1570
2022
Q4 		$1.08M Sell
38,669
-852
-2% -$24.7K ﹤0.01% 1681
2022
Q3 		$1.11M Buy
39,521
+2,581
+7% +$84.3K ﹤0.01% 1622
2022
Q2 		$1.28M Buy
36,940
+6,946
+23% +$248K ﹤0.01% 1539
2022
Q1 		$1.08M Buy
29,994
+10
+0% +$284 ﹤0.01% 1781
2021
Q4 		$698K Buy
29,984
+89
+0.3% +$1.82K ﹤0.01% 2054
2021
Q3 		$568K Sell
29,895
-90
-0.3% -$1.76K ﹤0.01% 2133
2021
Q2 		$604K Sell
29,985
-63
-0.2% -$1.19K ﹤0.01% 2109
2021
Q1 		$550K Sell
30,048
-229
-0.8% -$4.26K ﹤0.01% 2195
2020
Q4 		$609K Sell
30,277
-42
-0.1% -$817 ﹤0.01% 2041
2020
Q3 		$568K Buy
30,319
+2,091
+7% +$42.1K ﹤0.01% 1897
2020
Q2 		$634K Sell
28,228
-489
-2% -$8.96K ﹤0.01% 1791
2020
Q1 		$426K Buy
28,717
+1,434
+5% +$24.9K ﹤0.01% 1803
2019
Q4 		$526K Sell
27,283
-109
-0.4% -$2.09K ﹤0.01% 1869
2019
Q3 		$543K Sell
27,392
-175
-0.6% -$3.65K ﹤0.01% 1791
2019
Q2 		$582K Buy
27,567
+1,141
+4% +$23.9K ﹤0.01% 1733
2019
Q1 		$540K Buy
26,426
+2,027
+8% +$45.4K ﹤0.01% 1762
2018
Q4 		$486K Sell
24,399
-663
-3% -$13.1K ﹤0.01% 1591
2018
Q3 		$482K Buy
25,062
+440
+2% +$7.84K ﹤0.01% 1698
2018
Q2 		$376K Buy
24,622
+1,750
+8% +$30.6K ﹤0.01% 1818
2018
Q1 		$429K Buy
22,872
+572
+3% +$10.8K ﹤0.01% 1716
2017
Q4 		$429K Buy
22,300
+440
+2% +$8.22K ﹤0.01% 1760
2017
Q3 		$391K Buy
21,860
+250
+1% +$4.11K ﹤0.01% 1679
2017
Q2 		$386K Buy
21,610
+1,460
+7% +$23.2K ﹤0.01% 1652
2017
Q1 		$292K Buy
20,150
+710
+4% +$11.2K ﹤0.01% 1754
2016
Q4 		$358K Buy
19,440
+400
+2% +$7.78K ﹤0.01% 1647
2016
Q3 		$361K Buy
+19,040
New +$346K ﹤0.01% 1630

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Thrivent Financial for Lutherans's AMPH Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Amphastar Pharmaceuticals (AMPH) stake by 2.9% in Q1 2026, selling an estimated $17K and leaving 23,618 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Thrivent Financial for Lutherans first reported a position in AMPH in Q3 2016 and has held it in 39 quarters since. The position peaked at $5.07M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Thrivent Financial for Lutherans held 23,618 shares of Amphastar Pharmaceuticals worth $463K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 695 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $17K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2253 holding.
  • Thrivent Financial for Lutherans first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 39 quarters since.
  • Thrivent Financial for Lutherans's Amphastar Pharmaceuticals position peaked at $5.07M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.